Ilkka Ilonen

1.1k total citations
59 papers, 677 citations indexed

About

Ilkka Ilonen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ilkka Ilonen has authored 59 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 8 papers in Oncology. Recurrent topics in Ilkka Ilonen's work include Lung Cancer Diagnosis and Treatment (16 papers), Occupational and environmental lung diseases (16 papers) and Pleural and Pulmonary Diseases (15 papers). Ilkka Ilonen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), Occupational and environmental lung diseases (16 papers) and Pleural and Pulmonary Diseases (15 papers). Ilkka Ilonen collaborates with scholars based in Finland, United States and Sweden. Ilkka Ilonen's co-authors include Jari Räsänen, Jarmo Salo, Eero Sihvo, Aija Knuuttila, Harri Sintonen, Juha Kauppi, Marjukka Myllärniemi, Helena Isoniemi, Heikki Repo and Anssi Sovijärvi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and Scientific Reports.

In The Last Decade

Ilkka Ilonen

57 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilkka Ilonen Finland 15 382 232 153 90 63 59 677
Chao‐Hui Zheng China 18 843 2.2× 526 2.3× 364 2.4× 248 2.8× 72 1.1× 94 1.2k
Sandrine Lavau‐Denès France 15 183 0.5× 97 0.4× 338 2.2× 172 1.9× 37 0.6× 33 677
J.-M. Bréchot France 9 298 0.8× 134 0.6× 273 1.8× 146 1.6× 46 0.7× 34 794
Declan F.J. Dunne United Kingdom 13 239 0.6× 427 1.8× 350 2.3× 135 1.5× 32 0.5× 20 729
Mariam F. Eskander United States 17 252 0.7× 293 1.3× 459 3.0× 44 0.5× 140 2.2× 70 778
Hiroya Taniguchi Japan 14 180 0.5× 144 0.6× 232 1.5× 52 0.6× 67 1.1× 51 539
Luciano Frontini Italy 10 360 0.9× 87 0.4× 615 4.0× 119 1.3× 48 0.8× 16 943
Benoît Colinet Belgium 9 315 0.8× 68 0.3× 193 1.3× 46 0.5× 50 0.8× 22 512
Kathelijn S. Versteeg Netherlands 11 140 0.4× 148 0.6× 310 2.0× 329 3.7× 26 0.4× 21 621
Andrew Scarfe Canada 12 203 0.5× 159 0.7× 452 3.0× 392 4.4× 56 0.9× 21 889

Countries citing papers authored by Ilkka Ilonen

Since Specialization
Citations

This map shows the geographic impact of Ilkka Ilonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilkka Ilonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilkka Ilonen more than expected).

Fields of papers citing papers by Ilkka Ilonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilkka Ilonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilkka Ilonen. The network helps show where Ilkka Ilonen may publish in the future.

Co-authorship network of co-authors of Ilkka Ilonen

This figure shows the co-authorship network connecting the top 25 collaborators of Ilkka Ilonen. A scholar is included among the top collaborators of Ilkka Ilonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilkka Ilonen. Ilkka Ilonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verbiest, Annelies, Ilkka Ilonen, Michael Franz, et al.. (2025). 1867P FALCON-Lung: Evolving global ICI treatment patterns and outcomes in the era of personalized mNSCLC treatment. Annals of Oncology. 36. S1004–S1004. 1 indexed citations
2.
Nowlan, Kirsten, Lea Hedman, Pentti J. Tienari, et al.. (2024). Parvovirus B19 and Human Herpes Virus 6B and 7 Are Frequently Found DNA Viruses in the Human Thymus But Show No Definitive Link With Myasthenia Gravis. The Journal of Infectious Diseases. 231(4). e601–e606. 1 indexed citations
3.
Lahtinen, Laura, Mikko Räsänen, Karita Peltonen, et al.. (2024). Ex vivo modeling of precision immuno-oncology responses in lung cancer. Science Advances. 10(44). eadq6830–eadq6830. 2 indexed citations
4.
Mäyränpää, Mikko I., Lassi Paavolainen, Juuso Paajanen, et al.. (2022). Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma. Frontiers in Oncology. 12. 870352–870352. 5 indexed citations
5.
Kettunen, Eeva, Eva Sutinen, Ilkka Ilonen, et al.. (2022). Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 17(8). 1032–1041. 6 indexed citations
6.
Ilonen, Ilkka, et al.. (2021). General thoracic surgery in Finland, a perspective from the Helsinki University Hospital. Journal of Thoracic Disease. 14(6). 2335–2339. 1 indexed citations
7.
Kauppi, Juha, Sari Atula, Daniel Strbian, et al.. (2020). Improvement in symptom remission rate following robotic thymectomy in patients with myasthenia gravis. Interactive Cardiovascular and Thoracic Surgery. 30(6). 827–833. 5 indexed citations
8.
Paajanen, Juuso, Eeva Kettunen, Ilkka Ilonen, et al.. (2020). Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival. Human Pathology. 98. 110–119. 12 indexed citations
9.
10.
Robinson, Eric M., et al.. (2019). Thoracotomy and VATS Surgery in Local Non–Small-Cell Lung Cancer: Differences in Long-Term Health-Related Quality Of Life. Clinical Lung Cancer. 20(5). 378–383. 13 indexed citations
11.
Paajanen, Juuso, Ilkka Ilonen, Eva Sutinen, et al.. (2019). Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clinical Lung Cancer. 21(3). e142–e150. 24 indexed citations
12.
Ilonen, Ilkka, et al.. (2019). Malignant Peritoneal Mesothelioma: Treatment Options and Survival. Anticancer Research. 39(2). 839–845. 14 indexed citations
13.
Ilonen, Ilkka, et al.. (2018). Surgically Treated Unsuspected N2-Positive NSCLC: Role of Extent and Location of Lymph Node Metastasis. Clinical Lung Cancer. 19(5). 418–425. 7 indexed citations
14.
15.
Ilonen, Ilkka, et al.. (2018). Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World Journal of Surgical Oncology. 16(1). 27–27. 68 indexed citations
16.
Mustonen, Harri, Leena Krogerus, Ilkka Ilonen, et al.. (2016). Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma. Clinical & Translational Oncology. 19(1). 58–66. 8 indexed citations
17.
Ilonen, Ilkka & Philip McElnay. (2015). Research and education in thoracic surgery: the European trainees' perspective.. PubMed. 7(Suppl 2). S118–21. 10 indexed citations
18.
Ilonen, Ilkka, Jari Räsänen, Aija Knuuttila, et al.. (2010). Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study. Lung Cancer. 70(3). 347–351. 38 indexed citations
19.
Ilonen, Ilkka, Jari Räsänen, Eero Sihvo, et al.. (2009). Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione. Acta Oncologica. 48(7). 1054–1061. 20 indexed citations
20.
Ilonen, Ilkka, Anna‐Maria Koivusalo, Heikki Repo, Krister Höckerstedt, & Helena Isoniemi. (2007). Cytokine Profiles in Acute Liver Failure Treated With Albumin Dialysis. Artificial Organs. 32(1). 52–60. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao‐Hui Zheng Breakdown of academic impact, for papers by Sandrine Lavau‐Denès Breakdown of academic impact, for papers by J.-M. Bréchot Breakdown of academic impact, for papers by Declan F.J. Dunne Breakdown of academic impact, for papers by Mariam F. Eskander Breakdown of academic impact, for papers by Hiroya Taniguchi Breakdown of academic impact, for papers by Luciano Frontini Breakdown of academic impact, for papers by Benoît Colinet Breakdown of academic impact, for papers by Kathelijn S. Versteeg Breakdown of academic impact, for papers by Andrew Scarfe
Rankless by CCL
2026